Lucentis 10 mg/ml soluţie injectabilă Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

lucentis 10 mg/ml soluţie injectabilă

novartis pharma ag - ranibizumabum - soluţie injectabilă - 10 mg/ml

Lucentis solutie injectabila 10 mg/ml Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

lucentis solutie injectabila 10 mg/ml

novartis pharma ag - solutie injectabila - 10 mg/ml

Byooviz Uniunea Europeană - română - EMA (European Medicines Agency)

byooviz

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologice - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ximluci Uniunea Europeană - română - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ranivisio Uniunea Europeană - română - EMA (European Medicines Agency)

ranivisio

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Imazan™ 50 mg comprimate filmate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

imazan™ 50 mg comprimate filmate

eris pharmaceuticals (australia) pty ltd - azathioprinum - comprimate filmate - 50 mg

Panthron™ 20 mg comprimate filmate gastrorezistente Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

panthron™ 20 mg comprimate filmate gastrorezistente

eris pharmaceuticals (australia) pty ltd - letrozolum - comprimate filmate gastrorezistente - 20 mg

Panthron™ 40 mg comprimate filmate gastrorezistente Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

panthron™ 40 mg comprimate filmate gastrorezistente

eris pharmaceuticals (australia) pty ltd - letrozolum - comprimate filmate gastrorezistente - 40 mg

Jene-35 ED™ 2 mg + 0,035 mg comprimate; comprimate filmate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

jene-35 ed™ 2 mg + 0,035 mg comprimate; comprimate filmate

eris pharmaceuticals (australia) pty ltd - ethinylestradiolum + cyproteronum - comprimate; comprimate filmate - 2 mg + 0,035 mg

Cyrotone™ 50 mg comprimate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

cyrotone™ 50 mg comprimate

eris pharmaceuticals (australia) pty ltd - cyproteronum - comprimate - 50 mg